MENU
IBBQ
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

IBBQ stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®... Show more

Category: #Health
IBBQ
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IBBQ with price predictions
Sep 25, 2026

IBBQ in upward trend: price may jump up because it broke its lower Bollinger Band on September 10, 2026

IBBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 34 cases where IBBQ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 62 cases where IBBQ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on IBBQ as a result. In 74 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

Following a +0.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBBQ advanced for three days, in 263 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The 10-day RSI Indicator for IBBQ moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 20 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Moving Average Convergence Divergence Histogram (MACD) for IBBQ turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 42 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBBQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Illumina (NASDAQ:ILMN), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Guardant Health (NASDAQ:GH), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Nasdaq Biotechnology ETF (IBBQ) ETF is 8.58B. The market cap for tickers in the group ranges from 66.91M to 224.15B. AMGN holds the highest valuation in this group at 224.15B. The lowest valued company is GOSS at 66.91M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Nasdaq Biotechnology ETF (IBBQ) ETF was 2%. For the same ETF, the average monthly price growth was -4%, and the average quarterly price growth was 28%. GRAL experienced the highest price growth at 57%, while CGEM experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Invesco Nasdaq Biotechnology ETF (IBBQ) ETF was -62%. For the same stocks of the ETF, the average monthly volume growth was 14% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 70
Price Growth Rating: 53
SMR Rating: 86
Profit Risk Rating: 82
Seasonality Score: -12 (-100 ... +100)
View a ticker or compare two or three
IBBQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
PowerShares Exchange-Traded Fund Tr II301 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com
IBBQ in upward trend: price may jump up because it broke its lower Bollinger Band on September 10, 2026